About eGenesis
The Problem eGenesis addresses a core startup pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution eGenesis is a life sciences company focused on development and commercialization of engineered organisms for the benefit of human health. Biotech In practice, eGenesis centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, eGenesis is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on startup innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
eGenesis matters now because with the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, eGenesis is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series C • Khosla Ventures, $125M Series C in 2021, $99M valuation
Hiring Roles
This company is actively hiring.
Meet the Founders
eGenesis Team
Founder & CEO